These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 9433337)
1. Pretreatment attrition in a comparative treatment outcome study on panic disorder. Hofmann SG; Barlow DH; Papp LA; Detweiler MF; Ray SE; Shear MK; Woods SW; Gorman JM Am J Psychiatry; 1998 Jan; 155(1):43-7. PubMed ID: 9433337 [TBL] [Abstract][Full Text] [Related]
2. A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy. Marcus SM; Gorman J; Shear MK; Lewin D; Martinez J; Ray S; Goetz R; Mosovich S; Gorman L; Barlow D; Woods S Am J Psychiatry; 2007 Feb; 164(2):273-5. PubMed ID: 17267790 [TBL] [Abstract][Full Text] [Related]
3. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo. Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313 [TBL] [Abstract][Full Text] [Related]
4. The effect of pharmacotherapist characteristics on treatment outcome in panic disorder. Gorman JM; Martinez JM; Goetz R; Huppert JD; Ray S; Barlow DH; Shear MK; Woods SW Depress Anxiety; 2003; 17(2):88-93. PubMed ID: 12621597 [TBL] [Abstract][Full Text] [Related]
6. Predictors of entering a long-term drug treatment study of panic disorder. Mavissakalian MR; Guo S Compr Psychiatry; 2002; 43(2):88-94. PubMed ID: 11893985 [TBL] [Abstract][Full Text] [Related]
7. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. de Beurs E; van Balkom AJ; Lange A; Koele P; van Dyck R Am J Psychiatry; 1995 May; 152(5):683-91. PubMed ID: 7726307 [TBL] [Abstract][Full Text] [Related]
9. Attrition in a multicenter clinical trial for panic disorder. White KS; Allen LB; Barlow DH; Gorman JM; Shear MK; Woods SW J Nerv Ment Dis; 2010 Sep; 198(9):665-71. PubMed ID: 20823729 [TBL] [Abstract][Full Text] [Related]
10. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships. Mavissakalian MR; Perel JM Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306 [TBL] [Abstract][Full Text] [Related]
11. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Otto MW; Pollack MH; Sachs GS; Reiter SR; Meltzer-Brody S; Rosenbaum JF Am J Psychiatry; 1993 Oct; 150(10):1485-90. PubMed ID: 8379551 [TBL] [Abstract][Full Text] [Related]
12. Physical, mental, and social catastrophic cognitions as prognostic factors in cognitive-behavioral and pharmacological treatments for panic disorder. Hicks TV; Leitenberg H; Barlow DH; Gorman JM; Shear MK; Woods SW J Consult Clin Psychol; 2005 Jun; 73(3):506-14. PubMed ID: 15982148 [TBL] [Abstract][Full Text] [Related]
13. One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remission. Heldt E; Gus Manfro G; Kipper L; Blaya C; Isolan L; Otto MW Behav Res Ther; 2006 May; 44(5):657-65. PubMed ID: 16038874 [TBL] [Abstract][Full Text] [Related]
14. Emotion-focused psychotherapy for patients with panic disorder. Shear MK; Houck P; Greeno C; Masters S Am J Psychiatry; 2001 Dec; 158(12):1993-8. PubMed ID: 11729015 [TBL] [Abstract][Full Text] [Related]
15. Pretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder. Grilo CM; Money R; Barlow DH; Goddard AW; Gorman JM; Hofmann SG; Papp LA; Shear MK; Woods SW Compr Psychiatry; 1998; 39(6):323-32. PubMed ID: 9829138 [TBL] [Abstract][Full Text] [Related]
16. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants. Toni C; Perugi G; Frare F; Mata B; Vitale B; Mengali F; Recchia M; Serra G; Akiskal HS Pharmacopsychiatry; 2000 Jul; 33(4):121-31. PubMed ID: 10958260 [TBL] [Abstract][Full Text] [Related]
17. Integration of behavioral and pharmacological treatments for panic disorder: implications for the treatment of substance dependence. Otto MW; Pollack MH; Ball SG; Rosenbaum JF NIDA Res Monogr; 1995; 150():143-66. PubMed ID: 8742777 [No Abstract] [Full Text] [Related]
18. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. Clark DM; Salkovskis PM; Hackmann A; Middleton H; Anastasiades P; Gelder M Br J Psychiatry; 1994 Jun; 164(6):759-69. PubMed ID: 7952982 [TBL] [Abstract][Full Text] [Related]